Related Experiment Videos
Mental Disorders in People Affected by Thalidomide.
Alexander Niecke1, Klaus Peters, Christina Samel
1Department of Psychosomatics and Psychotherapy, University Hospital Cologne; Department of Orthopedics and Osteology, Dr. Becker Rhein-Sieg-Klinik Nümbrecht; Institute of Medical Statistics, Informatics and Epidemiology and Institute for Health Economics and Clinical Epidemiology, University of Cologne; Faculty of Business Management and Social Sciences, Osnabrück University of Applied Sciences; Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), University of Cologne & University Hospital Cologne.
Thalidomide survivors experience mental disorders twice as often as the general population. Despite high need, psychosocial healthcare utilization remains low, indicating a significant unmet need for specialized services.
Area of Science:
- Psychiatry
- Medical Sociology
- Public Health
Background:
- Thalidomide's legacy includes persistent orthopedic and psychosocial issues for affected individuals.
- Over 50 years post-market withdrawal, mental health remains a significant concern for thalidomide survivors.
Purpose of the Study:
- To determine the prevalence of mental disorders in individuals affected by thalidomide.
- To assess the utilization of mental health services among this population.
Main Methods:
- A cohort of 193 thalidomide-affected individuals underwent psychodiagnostic testing.
- Utilized Structured Clinical Interview for DSM-IV (SCID-I & SCID-II) and self-reporting questionnaires for comprehensive assessment.
Main Results:
- The four-week prevalence of mental disorders was 47.2%, with 45.1% experiencing multiple diagnoses.
- Unipolar depressive, somatoform, phobic, and alcohol-related disorders were most common.
- 80.2% with current mental disorders required immediate care, yet only 29.7% accessed psychosocial treatment in the past year.
Conclusions:
- Thalidomide-affected individuals exhibit mental disorders at nearly double the rate of the general population.
- A significant underuse of psychosocial healthcare services is evident in this group.
- Specialized treatment services are needed to improve access and address healthcare barriers.